A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PARs

Search Conditions:
Search Keyword : PARs
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: PARs
Appearance Frequency: 864 time(s)
Long forms: 43

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
protease-activated receptors
(717 times)
Pharmacology
(105 times)
TF (53 times)
GPCRs (34 times)
PAR (26 times)
1998 A CD4+ proliferation of large granular lymphocytes expresses the protease activated receptor-1.
population attributable risks
(61 times)
Neoplasms
(12 times)
CI (9 times)
BMI (6 times)
OR (6 times)
1994 Risk factors for gonorrhoea, syphilis, and trichomonas infections among women attending family planning clinics in Nairobi, Kenya.
pseudoautosomal regions
(23 times)
Molecular Biology
(9 times)
DSBs (3 times)
MI (2 times)
XTR (2 times)
1996 A synaptobrevin-like gene in the Xq28 pseudoautosomal region undergoes X inactivation.
physical activity referrals
(5 times)
Public Health
(2 times)
PA (2 times)
PARA (2 times)
PHC (2 times)
2005 The effect of social desirability and social approval on self-reports of physical activity.
predictive adaptive responses
(5 times)
Biology
(4 times)
GE (1 time)
IARs (1 time)
2012 The serotonin transporter gene and functional and pathological adaptation to environmental variation across the life span.
pulmonary artery rings
(5 times)
Physiology
(3 times)
LPS (3 times)
MDA (2 times)
PE (2 times)
2001 [Properties of peroxynitrite-induced relaxation in rabbit pulmonary artery in vitro].
personal attenuation ratings
(4 times)
Audiology
(3 times)
HPD (2 times)
ANOVA (1 time)
EXP-Fit (1 time)
2016 The viability of hearing protection device fit-testing at navy and marine corps accession points.
purity-activity relationships
(3 times)
Pharmacology
(2 times)
8-PN (1 time)
DMX (1 time)
QPAR (1 time)
2008 Purity-activity relationships of natural products: the case of anti-TB active ursolic acid.
police accident reports
(2 times)
Traumatology
(2 times)
E-code (1 time)
MVC (1 time)
NASS (1 time)
1994 Accuracy of fatal motorcycle-injury reporting on death certificates.
10  poly(ADP-ribosylated) proteins
(2 times)
Toxicology
(1 time)
PARP-1 (2 times)
3-AB (1 time)
AIF (1 time)
2012 A dual role for poly(ADP-ribose) polymerase-1 during caspase-dependent apoptosis.
11  protease-activated G-protein-coupled receptors
(2 times)
Hematology
(1 time)
mPAR3 (1 time)
2000 PAR3 is a cofactor for PAR4 activation by thrombin.
12  protective action recommendations
(2 times)
Environmental Health
(2 times)
NRC (1 time)
2000 An overview of protective action decision-making for a nuclear power plant emergency.
13  Protein affinity reagents
(2 times)
Proteome
(1 time)
APARs (1 time)
NPs (1 time)
PSI (1 time)
2010 A community standard format for the representation of protein affinity reagents.
14  proteolytically activated receptors
(2 times)
Biochemistry
(1 time)
PAR-3 (1 time)
1998 The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a Par gene cluster and characterization in vascular endothelial cells and platelets.
15  GPCRs-protease-activated receptors
(1 time)
Cell Biology
(1 time)
BRET (1 time)
GPCRs (1 time)
RGS (1 time)
2016 Regulator of G protein signaling 8 inhibits protease-activated receptor 1/Gi/o signaling by forming a distinct G protein-dependent complex in live cells.
16  PA records
(1 time)
Epidemiology
(1 time)
FWH (1 time)
PA (1 time)
SAFE (1 time)
1999 Intra-individual variation and estimates of usual physical activity.
17  PA resources
(1 time)
Psychology
(1 time)
AA (1 time)
BMI (1 time)
CVD (1 time)
2016 An exploratory decision tree analysis to predict cardiovascular disease risk in African American women.
18  partitioning proteins
(1 time)
Cell Biology
(1 time)
a-p (1 time)
MFs (1 time)
MTs (1 time)
2003 Myosin and the PAR proteins polarize microfilament-dependent forces that shape and position mitotic spindles in Caenorhabditis elegans.
19  percent area reductions
(1 time)
Traumatology
(1 time)
SOC (1 time)
2020 A retrospective matched-cohort study of 3994 lower extremity wounds of multiple etiologies across 644 institutions comparing a bioactive human skin allograft, TheraSkin, plus standard of care, to standard of care alone.
20  percentages of attributable risk
(1 time)
Public Health
(1 time)
SMR (1 time)
YPLL (1 time)
2007 Years of potential life lost in residents affected by floods in Hunan, China.
21  perfused area rates
(1 time)
Nuclear Medicine
(1 time)
P index (1 time)
PPH (1 time)
RVEF (1 time)
2002 Quantitative analysis of lung perfusion in patients with primary pulmonary hypertension.
22  periapophyseal regions
(1 time)
Tissue Engineering
(1 time)
IARs (1 time)
SF (1 time)
SSCs (1 time)
2010 Graft vascularization is a critical rate-limiting step in skeletal stem cell-mediated posterolateral spinal fusion.
23  personally autonomous reasons
(1 time)
Psychology
(1 time)
--- 2006 Pursuing goals for us: relationally autonomous reasons in long-term goal pursuit.
24  phased array radars
(1 time)
Biosensing Techniques
(1 time)
GA-MMC (1 time)
GAs (1 time)
PAs (1 time)
2014 Genetic algorithm with maximum-minimum crossover (GA-MMC) applied in optimization of radiation pattern control of phased-array radars for rocket tracking systems.
25  physical activity ratios
(1 time)
Metabolism
(1 time)
EEact (1 time)
RMR (1 time)
TEE (1 time)
1995 Energy cost of physical activities in healthy elderly women.
26  pillar-anchored repairs
(1 time)
General Surgery
(1 time)
DRs (1 time)
LAW (1 time)
SSIs (1 time)
2019 Surgical Outcomes in Lateral Abdominal Wall Reconstruction: A Comparative Analysis of Surgical Techniques.
27  plain abdominal radiographs
(1 time)
Emergency Medicine
(1 time)
EP (1 time)
IVPs (1 time)
1985 Usefulness of abdominal flat plate radiographs in patients with suspected ureteral calculi.
28  platelet activation rates
(1 time)
Transplantation
(1 time)
AVs (1 time)
LVAD (1 time)
MCS (1 time)
2011 Thrombogenic potential of Innovia polymer valves versus Carpentier-Edwards Perimount Magna aortic bioprosthetic valves.
29  poly(ADP-ribose) chains
(1 time)
Biochemistry
(1 time)
PARP1 (1 time)
2018 A rapid fluorescent method for the real-time measurement of poly(ADP-ribose) polymerase 1 activity.
30  poly(ADP-ribosyl)ation and that ADP-ribose polymers
(1 time)
Biochemistry
(1 time)
CTCF (1 time)
2008 CCCTC-binding factor activates PARP-1 affecting DNA methylation machinery.
31  population attributable risk percents
(1 time)
Neoplasms
(1 time)
EPRT (1 time)
RR (1 time)
2006 Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors.
32  positive anatomical regions
(1 time)
Brain
(1 time)
ECoG (1 time)
FDG-PET (1 time)
SOZ (1 time)
2014 Can we increase the yield of FDG-PET in the preoperative work-up for epilepsy surgery?
33  positive association rules
(1 time)
Medicine
(1 time)
NARs (1 time)
2014 Negative and positive association rules mining from text using frequent and infrequent itemsets.
34  potentially avoidable readmissions
(1 time)
Medical Oncology
(1 time)
--- 2019 Potentially Avoidable Hospital Readmissions in Patients With Advanced Cancer.
35  processes through the activation of specific receptors
(1 time)
Medicine
(1 time)
HDC (1 time)
HMC (1 time)
IL (1 time)
2006 Inhibitory effect of quercetin on tryptase and interleukin-6 release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line.
36  Prognostic implications of co-morbidities
(1 time)
Cardiology
(1 time)
CKD (1 time)
ESC (1 time)
HF (1 time)
2014 Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey.
37  promoter-associated RNAs
(1 time)
Genetic Phenomena
(1 time)
CUTs (1 time)
ncRNAs (1 time)
PROMPTs (1 time)
2018 Classification of Transcription Boundary-Associated RNAs (TBARs) in Animals and Plants.
38  prosthetic antigen receptors
(1 time)
Nanotechnology
(1 time)
CSANs (1 time)
EpCAM (1 time)
2018 Eradication of Established Tumors by Chemically Self-Assembled Nanoring Labeled T Cells.
39  Protease-activated cell surface receptors
(1 time)
Hematology
(1 time)
--- 2002 Current perspective on antithrombin drugs.
40  proteolytically active thrombin receptors
(1 time)
Cell Biology
(1 time)
non-PAR (1 time)
2006 The non-proteolytically active thrombin peptide TP508 stimulates angiogenic sprouting.
41  provisional acceptable residues
(1 time)
Pharmacology
(1 time)
ADI (1 time)
1999 Estimating provisional acceptable residues for extralabel drug use in livestock.
42  Pseudoallergic reactions
(1 time)
Allergy and Immunology
(1 time)
--- 2002 Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria.
43  thrombin-protease-activated receptors
(1 time)
Rheumatology
(1 time)
ANCA (1 time)
2017 Platelets are activated in ANCA-associated vasculitis via thrombin-PARs pathway and can activate the alternative complement pathway.